(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD executed) (NP (DT a) (JJ genomic) (NN analysis)) (PP (IN with) (NP (NP (DT the) (NN objective)) (PP (IN of) (S (VP (VBG selecting) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NP (NP (NNS genes)) (-LRB- -LRB-) (ADJP (RB possibly) (JJ small)) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (VP (MD would) (VP (VB help) (PP (IN in) (NP (NP (DT the) (NN detection) (CC and) (NN classification)) (PP (IN of) (NP (NNS samples))))) (PP (IN from) (NP (NP (NNS patients)) (VP (VBN affected) (PP (IN by) (NP (NNP Parkinson) (NNP Disease))))))))))))))))))) (. .))
(S (S (NP (PRP We)) (VP (VBD performed) (NP (DT a) (JJ complete) (NN data) (NN analysis)))) (CC and) (S (PP (IN during) (NP (DT the) (JJ exploratory) (NN phase))) (, ,) (NP (PRP we)) (VP (VBD selected) (NP (NP (DT a) (NN list)) (PP (IN of) (NP (ADJP (RB differentially) (VBN expressed)) (NNS genes)))))) (. .))
(S (PP (IN Despite) (NP (NP (PRP$ their) (NN association)) (PP (IN with) (NP (DT the) (JJ diseased) (NN state))))) (, ,) (NP (PRP we)) (VP (MD could) (RB not) (VP (VB use) (NP (PRP them)) (PP (IN as) (NP (DT a) (NN biomarker) (NN tool))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP (PRP$ our) (NN research)) (VP (VBD was) (VP (VBN extended) (S (VP (TO to) (VP (VP (VB include) (NP (NP (DT a) (JJ multivariate) (NN analysis) (NN approach)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT the) (NN identification) (CC and) (NN selection)) (PP (IN of) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (CD 20) (NNS genes)) (SBAR (WHNP (WDT that)) (S (VP (VBD showed) (NP (DT a) (JJ clear) (NN potential)) (PP (IN in) (S (VP (VBG detecting)))))))))))))))) (CC and) (ADVP (RB correctly)) (VP (VB classify) (NP (NNP Parkinson) (NNP Disease) (NNS samples)) (ADVP (RB even)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ other) (JJ neurodegenerative) (NNS disorders))))))))))) (. .))
